In an era dominated by algorithms and automation, new research from the University of Miami Patti and Allan Herbert Business ...

Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) ...

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Induction Trial Results in Participants With and Without Prior ...

Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA nephropathyJADE101 is an investigational, potentially best-in-class ...

Representatives from Cloverleaf gave a presentation on what a data center is and addressing some of the common concerns ...

India's Rs 28,000 crore data center boom is accelerating, driven by cloud and AI growth. These 3 emerging players are poised ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

The recently concluded South African leg of Qlik's AI Reality Tour unpacked how companies can turn data strategy into ...

(NASDAQ:MRNA) today announced that clinical, safety and translational data from its Phase 1/2 study evaluating mRNA-4359 in ...

MUMBAI, India and NAPLES, Fla. and BERLIN, Oct. 13, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) will ...

The use of cameras by law enforcement to automatically scan license plates and record vehicle information in an online ...

ANZ outlines a cost-focused strategy under new CEO Nuno Matos, with execution risks and limited innovation. Find out why ...